<SEC-DOCUMENT>0001193125-23-253805.txt : 20231011
<SEC-HEADER>0001193125-23-253805.hdr.sgml : 20231011
<ACCEPTANCE-DATETIME>20231011060656
ACCESSION NUMBER:		0001193125-23-253805
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20231010
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231011
DATE AS OF CHANGE:		20231011

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Walgreens Boots Alliance, Inc.
		CENTRAL INDEX KEY:			0001618921
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				471758322
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36759
		FILM NUMBER:		231319372

	BUSINESS ADDRESS:	
		STREET 1:		108 WILMOT ROAD
		CITY:			DEERFIELD
		STATE:			IL
		ZIP:			60015
		BUSINESS PHONE:		(847) 315-2500

	MAIL ADDRESS:	
		STREET 1:		108 WILMOT ROAD
		CITY:			DEERFIELD
		STATE:			IL
		ZIP:			60015
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d559360d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:wba="http://walgreensbootsalliance.com/20231010" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-10-10_to_2023-10-10">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-10-10_to_2023-10-10">0001618921</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="wba-20231010.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-10-10_to_2023-10-10"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001618921</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-10-10</xbrli:startDate> <xbrli:endDate>2023-10-10</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001618921</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-10-10</xbrli:startDate> <xbrli:endDate>2023-10-10</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_wba-M3.600WalgreensBootsAllianceInc.NotesDue2025Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001618921</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wba:M3.600WalgreensBootsAllianceInc.NotesDue2025Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-10-10</xbrli:startDate> <xbrli:endDate>2023-10-10</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_wba-M2.125WalgreensBootsAllianceInc.NotesDue2026Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001618921</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wba:M2.125WalgreensBootsAllianceInc.NotesDue2026Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-10-10</xbrli:startDate> <xbrli:endDate>2023-10-10</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-10-10_to_2023-10-10">8-K</ix:nonNumeric></span></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-10-10_to_2023-10-10" format="ixt:datemonthdayyearen">October&#160;10, 2023</ix:nonNumeric></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2023-10-10_to_2023-10-10">WALGREENS BOOTS ALLIANCE, INC.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-10-10_to_2023-10-10" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-10-10_to_2023-10-10">001-36759</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-10-10_to_2023-10-10">47-1758322</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification Number)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-10-10_to_2023-10-10">108 Wilmot Road</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-10-10_to_2023-10-10">Deerfield</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-10-10_to_2023-10-10" format="ixt-sec:stateprovnameen">Illinois</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-10-10_to_2023-10-10">60015</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-10-10_to_2023-10-10">(847)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-10-10_to_2023-10-10">315-2500</ix:nonNumeric></span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-10-10_to_2023-10-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-10-10_to_2023-10-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-10-10_to_2023-10-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-10-10_to_2023-10-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Securities Exchange Act of 1934:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">Common Stock, $0.01 par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">WBA</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_wba-M3.600WalgreensBootsAllianceInc.NotesDue2025Member">3.600% Walgreens Boots Alliance, Inc. notes due 2025</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_wba-M3.600WalgreensBootsAllianceInc.NotesDue2025Member">WBA25</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_wba-M3.600WalgreensBootsAllianceInc.NotesDue2025Member" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_wba-M2.125WalgreensBootsAllianceInc.NotesDue2026Member">2.125% Walgreens Boots Alliance, Inc. notes due 2026</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_wba-M2.125WalgreensBootsAllianceInc.NotesDue2026Member">WBA26</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_wba-M2.125WalgreensBootsAllianceInc.NotesDue2026Member" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-10-10_to_2023-10-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold"><span style="text-decoration:underline">Item</span><span style="text-decoration:underline">&#8201;</span><span style="text-decoration:underline">5.02</span>.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left"><span style="text-decoration:underline">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</span>. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Appointment of Timothy Charles Wentworth as Chief Executive Officer and as a member of the Board of Directors </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October&#160;10, 2023, the Board of Directors (the &#8220;Board&#8221;) of Walgreens Boots Alliance, Inc. (the &#8220;Company&#8221;) appointed Timothy Charles Wentworth as Chief Executive Officer (&#8220;CEO&#8221;) of the Company, effective as of October&#160;23, 2023 (the &#8220;Effective Date&#8221;). Mr.&#160;Wentworth was also appointed as a member of the Board, effective as of the Effective Date. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Wentworth, 63, previously served as Chief Executive Officer of Evernorth Health Services, a division of The Cigna Group (&#8220;Cigna&#8221;), from September 2020 to December 2021 and as President, Health Services of Cigna from February 2020 to December 2021. From December 2018, following the merger of Express Scripts Holding Company (&#8220;Express Scripts&#8221;) with Cigna, until February 2020, Mr.&#160;Wentworth served as President, Express Scripts and Cigna Services. Prior to the aforementioned merger, he served as Chief Executive Officer of Express Scripts from May 2016 until December 2018 and in various leadership roles at Express Scripts from April 2012 until his appointment as Chief Executive Officer in May 2016. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Wentworth serves as a member of the board of trustees of the University of Rochester, a director of the Concordance Academy of Leadership in St.&#160;Louis, Missouri and an executive committee member of the board of directors of the Opera Theatre of St. Louis. He previously served as a member of the board of trustees of Teachers College, Columbia University. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with his appointment as CEO, the Company entered into an employment agreement with Mr.&#160;Wentworth (the &#8220;Employment Agreement&#8221;) setting forth the terms of his employment and compensation. The Employment Agreement has no specified term and his employment with the Company will be on an <span style="white-space:nowrap">at-will</span> basis. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the Employment Agreement, Mr.&#160;Wentworth will be entitled to an initial annualized base salary of $1,500,000, subject to future adjustments as determined by the Company&#8217;s Compensation and Leadership Performance Committee of the Board (the &#8220;Compensation Committee&#8221;), and will be eligible for an annual bonus with a target payout of 200% of base salary under the Company&#8217;s corporate bonus program. Mr.&#160;Wentworth will also be eligible for long-term incentives pursuant to the WBA 2021 Omnibus Incentive Plan (the &#8220;Omnibus Plan&#8221;) on the terms and conditions determined by the Compensation Committee. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the approval of the Board or the Compensation Committee, within 60 days following the Effective Date, the Company will make an initial incentive equity grant to Mr.&#160;Wentworth with a grant date value equal to $12,000,000. This equity incentive award will be granted with terms and conditions consistent with the long-term incentive plan applicable to the Company&#8217;s executive officers, which is expected to be comprised of 50% performance stock units and 50% restricted stock units, each vesting over three years. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Wentworth will also be covered by the Company&#8217;s Executive Severance and Change in Control Plan (as amended and restated effective August&#160;6, 2019), a copy of which is filed as Exhibit 10.34 to the Company&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> for the fiscal year ended August&#160;31, 2022 filed with the Securities and Exchange Commission on October&#160;13, 2022 and which is incorporated herein by reference. Mr.&#160;Wentworth will also be entitled to relocation benefits and personal use of the Company&#8217;s corporate aircraft up to a maximum of 75 hours per fiscal year. As a condition to his employment as CEO, Mr.&#160;Wentworth will enter into a <span style="white-space:nowrap">non-competition,</span> <span style="white-space:nowrap">non-solicitation</span> and confidentiality agreement with the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of Mr.&#160;Wentworth&#8217;s Employment Agreement and compensation arrangements does not purport to be complete and is qualified in its entirety by reference to the Employment Agreement which is attached as Exhibit 10.1 to this report and incorporated by reference herein. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Wentworth has no family relationships with any director or executive officer of the Company, and there are no arrangements or understandings with any person pursuant to which he was selected as an officer of the Company. In addition, there have been no transactions directly or indirectly involving Mr.&#160;Wentworth that would be required to be disclosed pursuant to Item 404(a) of Regulation <span style="white-space:nowrap">S-K</span> under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold"><span style="text-decoration:underline">Item</span><span style="text-decoration:underline">&#8201;</span><span style="text-decoration:underline">7.01.</span></span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left"><span style="text-decoration:underline">Regulation FD Disclosure.</span> </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October&#160;10, 2023, the Company issued a press release announcing the appointment of Mr.&#160;Wentworth as Chief Executive Officer and member of the Board effective on the Effective Date, a copy of which is furnished as Exhibit 99.1 hereto and incorporated in this Item 7.01 by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information in this Item 7.01 and Exhibit 99.1 shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Exchange Act or otherwise subject to the liabilities of that section. This information shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, expect as shall be expressly set forth by specific reference to such disclosure in this Form <span style="white-space:nowrap">8-K</span> in such a filing. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold"><span style="text-decoration:underline">Item</span><span style="text-decoration:underline">&#8201;</span><span style="text-decoration:underline">9.01</span>.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left"><span style="text-decoration:underline">Financial Statements and</span><span style="text-decoration:underline"></span><span style="text-decoration:underline">&#160;Exhibits</span>. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) <span style="text-decoration:underline">Exhibits</span> </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center">Exhibit</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Description</td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d559360dex101.htm">Employment Agreement between Walgreens Boots Alliance, Inc. and Timothy Charles Wentworth dated October&#160;9, 2023 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d559360dex991.htm">Press Release issued by Walgreens Boots Alliance, Inc. on October&#160;10, 2023 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (formatted as inline XBRL)</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:44%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">WALGREENS BOOTS ALLIANCE, INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: October&#160;11, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Joseph B. Amsbary Jr.</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Senior Vice President and Corporate Secretary</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">4 </p>

</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d559360dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Confidential </I></B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EMPLOYMENT AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This Employment Agreement (this &#147;<B><I>Agreement</I></B>&#148;) by and between Walgreens Boots Alliance, Inc., a Delaware corporation
(the &#147;<B><I>Company</I></B>&#148;), and Timothy C. Wentworth (&#147;<B><I>Employee</I></B>&#148;) is entered into as of October&nbsp;9, 2023 (the &#147;<B><I>Effective Date</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1</B>&#8195;<B><U>Employment and Term</U></B>. The Company (or a subsidiary thereof) hereby agrees to employ Employee, and Employee hereby
agrees to be employed by the Company, on the terms and subject to the conditions set forth in this Agreement. The parties agree that the term of this Agreement shall (a)&nbsp;commence on October&nbsp;23, 2023 (such date, the &#147;<B><I>Commencement
Date</I></B>&#148;), and (b)&nbsp;shall end on Employee&#146;s Termination Date (as defined in the Company&#146;s Executive Severance and Change in Control Plan (the &#147;<B><I>Severance Plan</I></B>&#148;)), as it may be amended from time to time.
The period of Employee&#146;s employment with the Company pursuant to the terms hereof shall be referred to herein as the &#147;<B><I>Employment Period</I></B>.&#148; Unless otherwise agreed to in writing, this Agreement shall be null and void,
<I>ab initio</I>, if the Employment Period does not commence on or prior to November&nbsp;1, 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2</B>&#8195;<B><U>Position and
Duties</U></B>. The Company shall employ Employee during the Employment Period as its Chief Executive Officer, or in such other position(s) as may be agreed between the parties. Employee shall report solely and directly to the Company&#146;s Board
of Directors (the &#147;<B><I>Board</I></B>&#148;). During the Employment Period, Employee shall have the responsibilities and duties as those normally associated with such position in companies of a similar nature and stature, as well as such other
responsibilities as may, from time to time, be duly authorized or directed by the Board. During the Employment Period, Employee shall perform faithfully and loyally and to the best of his abilities the duties assigned to him hereunder. Employee
shall act at all times in accordance with what is in the best interests of the Company. During the Employment Period, Employee shall devote his full business time, attention and effort to the affairs of the Company, its parent and subsidiary
corporations, affiliates, successors and assigns and shall not, during the Employment Period, be engaged in any other business activity whether or not such business activity is pursued for gain, profit or other pecuniary advantage, without the prior
written consent of the Board. The foregoing is not intended to restrict Employee&#146;s ability to: (a)&nbsp;engage in charitable, civic or community activities to the extent that such activities do not materially interfere with his duties
hereunder; (b)&nbsp;serve on the board of directors (or similar governing bodies) of a company (other than the Company); <U>provided</U> that, the Board, in its sole discretion, has granted prior written consent; nor (c)&nbsp;to enter into passive
investments that do not compete in any way with the Company&#146;s business. Employee shall work full-time from the Company&#146;s headquarters (currently in Deerfield, Illinois). The Company shall take all actions necessary to appoint Employee to
the Board on or promptly following the Commencement Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3</B>&#8195;<B><U>Compensation</U></B>. Employee acknowledges and agrees
that Employee&#146;s right to compensation under this Agreement shall terminate on the Termination Date except as otherwise provided hereunder. As compensation in full for services to be rendered by Employee hereunder, the Company shall pay to
Employee the following compensation: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.1&#8195;<U>Base Salary</U>. During the Employment Period, Employee shall be paid an annual base
salary (the &#147;<B><I>Base Salary</I></B>&#148;) at the annualized rate of $1,500,000. Employee&#146;s Base Salary shall be paid to him according to the regular payroll schedule used for employees generally. Employee&#146;s Base Salary shall be
subject to future adjustments as determined by the Compensation and Leadership Performance Committee of the Board (the &#147;<B><I>Compensation Committee</I></B>&#148;). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.2&#8195;<U>Annual Bonus</U>. Employee shall be eligible to earn an annual bonus with a
target amount equivalent to 200% of the Base Salary (or such other base earnings calculation as applicable) in accordance with the Company&#146;s bonus plan applicable to executive officers of the Company. The actual amount of the bonus payable with
respect to a fiscal year (the &#147;<B><I>Bonus</I></B>&#148;) shall be determined by the Compensation Committee. The Bonus shall be paid in accordance with the plans, policies and procedures adopted by the Compensation Committee from time to time,
but paid through the Company&#146;s payroll process. Except as applicable under the Severance Plan, Employee must not have previously given Notice of Termination (as defined in the Severance Plan) and must be employed by the Company on the day of
the payout to receive the Bonus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.3&#8195;<U>Long-Term Incentive Compensation</U>. Employee shall be eligible to participate in the
Company&#146;s long-term incentive compensation program (which is currently provided pursuant to the Company&#146;s 2021 Omnibus Incentive Plan (the &#147;<B><I>Omnibus Plan</I></B>&#148;)) on the terms and conditions determined by the Compensation
Committee and communicated to Employee. Subject to the approval of the Board or its designee, within 60 days following the Commencement Date, the Company shall grant Employee equity incentives under the Omnibus Plan with a grant date value equal to
$12,000,000, which will be subject to the terms and conditions of the equity-based incentive awards provided to the Company&#146;s executive officers (the &#147;<B><I>Initial Grant</I></B>&#148;). The Initial Grant shall be granted with terms and
conditions consistent with the long-term incentive plan applicable to the Company&#146;s executive officers, which is expected to be comprised of restricted stock units. Fifty percent (50%) of the Initial Grant shall vest over time in equal
installments on the first, second and third anniversaries of the date of grant, and the remaining 50% of the Initial Grant shall vest at the end of a three-year performance period based on the achievement of certain performance metrics detailed in
the applicable performance stock unit award agreement (in each case, subject to continued employment or service through the applicable vesting date). Notwithstanding anything to the contrary set forth in the Omnibus Plan or any award agreement
granted to Employee thereunder or the Severance Plan, to the extent Employee becomes entitled to any accelerated vesting or other special benefits under the Omnibus Plan or the Severance Plan due to a termination of employment for any reason, such
accelerated vesting or special benefits shall be subject to Employee timely delivering to the Company (and not subsequently revoking) a general waiver and release of claims in favor of the Company and its related parties in such form and with such
terms and conditions as are reasonably acceptable to the Company (which release shall include an affirmation of all restrictive covenants owed to the Company and its related parties). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.4&#8195;<U>Benefits</U>. During the Employment Period, Employee shall be entitled to participate in the Company&#146;s and its
subsidiaries&#146; employee benefit plans or programs generally available to similarly situated executive employees of the Company, including all health, dental, drug and vision coverage, life insurance and financial planning benefits;
<U>provided</U> that, Employee meets all eligibility requirements under each such plan or program. Employee&#146;s participation in the employee benefit plans or programs shall be subject to the terms and conditions of said plans or programs,
including, without limitation, the Company&#146;s and its subsidiaries&#146; right to amend, revise, terminate or replace the plans or programs at any time and without notice to participants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.5&#8195;<U>Expense Reimbursement</U>. During the Employment Period, the Company and its subsidiaries, as applicable, shall reimburse
Employee, in accordance with the Company&#146;s and its subsidiaries&#146; policies and procedures, for all proper and reasonable expenses incurred by him in the performance of his duties hereunder. Additionally, (a)&nbsp;in connection with any
reasonable expenses associated with Employee&#146;s relocation to the Chicagoland area to perform his duties hereunder, the Company will provide reimbursements for such expenses in accordance with Company policy, and (b)&nbsp;the Company will work
with Employee in good faith to audit Employee&#146;s personal security needs and provide reasonable personal security assistance during the Employment Period, in each of cases (a)&nbsp;and (b), in accordance with the Company&#146;s and its
subsidiaries&#146; policies and procedures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 2 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.6&#8195;<U>Corporate Aircraft</U>. Subject to Employee&#146;s compliance with the
Company&#146;s and its subsidiaries&#146; policies and procedures with respect to corporate air travel, Employee shall have access to the Company&#146;s corporate aircraft for business travel purposes. Additionally, subject to Employee&#146;s
compliance with the Company&#146;s and its subsidiaries&#146; policies and procedures with respect to corporate air travel, Employee shall also have access to the Company&#146;s corporate aircraft for personal travel up to 75 hours per fiscal year <FONT
STYLE="white-space:nowrap">(pro-rated</FONT> for partial years of service). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.7&#8195;<U>Claw Back</U>. Employee acknowledges and agrees
that any compensation or benefits paid to Employee by the Company, pursuant to this Agreement or otherwise, shall be subject to recovery by the Company if Employee violates any of his restrictive covenant obligations owed to the Company or in
accordance with Section&nbsp;304 of the Sarbanes-Oxley Act of 2002 or any other claw back law, policy or regulation applicable to executives of the Company, if any, as amended from time to time, and any claw back provisions provided in any bonus or
equity grant documents or the Company&#146;s equity compensation plan or pursuant to other Company policies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4</B>&#8195;<B><U>Termination</U></B>. The Employment Period shall terminate on the earliest Termination Date to occur due to the
following: (a)&nbsp;Employee&#146;s death; (b); Employee&#146;s Disability (as defined in the Severance Plan); (c) Employee&#146;s termination by the Company with or without Cause (as defined in the Severance Plan and at the request of the Board);
and (d)&nbsp;Employee&#146;s resignation from the Company with or without Good Reason (as applicable and defined in the Severance Plan). Employee shall be entitled to participate in the Severance Plan and will receive only the payments and benefits
(if any) pursuant to all of its terms, conditions, triggering events, and restrictions. For the avoidance of doubt and consistent with the Severance Plan, Employee&#146;s Termination Date shall occur (and the Employment Period shall end) on the date
designated by the Company (or by Employee in the case of a voluntary termination, subject to earlier termination by the Company in its sole discretion). Upon any termination of Employee&#146;s employment for any reason, except as may otherwise
approved by the Board and agreed upon by Employee in writing, Employee shall immediately and automatically be deemed to resign from and relinquish any and all directorships, committee memberships, powers of attorney, signature authorizations, and
any other positions Employee holds with or on behalf of the Company or any of its subsidiaries and affiliates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5</B>&#8195;<B><U>Indemnification</U></B>. In the event that Employee is made a party or threatened to be made a party to any action or
suit brought by a former employer based on Employee&#146;s employment with the Company, the Company shall indemnify and hold harmless Employee, subject to any limitations under applicable law and subject to and in accordance with the Company&#146;s
Bylaws, D&amp;O policies, and any other applicable indemnification agreements and arrangements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6</B>&#8195;<B><U>Restrictive
Covenants</U></B>. As a condition to the commencement of the Employment Period, Employee shall execute the <FONT STYLE="white-space:nowrap">Non-Competition,</FONT> <FONT STYLE="white-space:nowrap">Non-Solicitation</FONT> and Confidentiality
Agreement attached hereto as <U>Exhibit A</U>. Employee may also be subject to similar agreements as a condition to certain awards under the Omnibus Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 3 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7</B>&#8195;<B><U>Notices</U></B>. All notices and other communications required or
permitted hereunder shall be in writing and shall be deemed given when (a)&nbsp;delivered personally or by overnight courier to the following address of the other party hereto (or such other address for such party as shall be specified by notice
given pursuant to this <U>Section</U><U></U><U>&nbsp;7</U>) or (b)&nbsp;sent by email to the following facsimile number of the other party hereto (or such other facsimile number for such party as shall be specified by notice given pursuant to this
<U>Section</U><U></U><U>&nbsp;7</U>), with the confirmatory copy delivered by overnight courier to the address of such party pursuant to this <U>Section</U><U></U><U>&nbsp;7</U>: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>If to the Company, to: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Walgreens Boots Alliance, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: Stefano Pessina </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">108 Wilmot Road </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Deerfield, Illinois 60015 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Email: [Redacted] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>With a copy to the Company&#146;s General Counsel, at: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Walgreens Boots Alliance, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: General Counsel </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">108 Wilmot Road </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Deerfield, Illinois 60015 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Email: [Redacted] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>If to Employee, to: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">the most recent home address on file with the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8</B>&#8195;<B><U>Severability</U></B>.<B> </B>Whenever possible, each provision of this Agreement (and any exhibit attached hereto) shall
be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under applicable law or rule in any jurisdiction, such invalidity,
illegality or unenforceability shall not affect the validity, legality or enforceability of any other provision of this Agreement or the validity, legality or enforceability of such provision in any other jurisdiction, but this Agreement shall be
reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9</B>&#8195;<B><U>Entire Agreement</U></B>. This Agreement constitutes the entire agreement and understanding between the parties with
respect to the subject matter hereof and supersedes and preempts any prior understandings, agreements or representations by or between the parties, written or oral, which may have related in any manner to the subject matter hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10</B>&#8195;<B><U>Successors and Assigns</U></B>. This Agreement may not be assigned by either party without the written consent of the
other party hereto. Except as stated herein, nothing in this Agreement, expressed or implied, is intended to confer on any person other than the parties and their respective successors and permitted assigns any rights or remedies under or by reason
of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>11</B>&#8195;<B><U>Withholding</U></B>. All amounts payable hereunder will be subject to deduction for all required
income, payroll and other withholdings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12</B>&#8195;<B><U>Governing Law</U></B>. The laws of the State of Illinois will govern all
questions concerning the relative rights of the Company and all other questions concerning the construction, validity and interpretation of this Agreement and the exhibits hereto, without giving effect to any choice of law or conflict of law
provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 4 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13</B>&#8195;<B><U>Arbitration</U></B>.&nbsp;Any dispute, claim or controversy arising
under or in connection with this Agreement (and any exhibits hereto) or Employee&#146;s employment hereunder or the termination thereof shall be settled exclusively by arbitration administered by the American Arbitration Association (the
&#147;<U>AAA</U>&#148;) and carried out in Chicago, Illinois. The arbitration shall be conducted in accordance with the AAA&#146;s Commercial Arbitration Rules in effect at the time of the arbitration (the &#147;<U>AAA Rules</U>&#148;), except as
modified herein. There shall be one arbitrator mutually selected by the Company and Employee, within 30 days of receipt by respondent of the demand for arbitration. If the Company and Employee cannot mutually agree on an arbitrator within 30 days,
then an arbitrator shall be promptly appointed by the AAA in accordance with the AAA Rules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.1&#8195;The arbitration hearings shall
(except to the extent otherwise reasonably provided by the arbitrator for good cause or as otherwise mutually agreed by the parties) commence within 45 days after the appointment of the arbitrator; the arbitration shall (except to the extent
otherwise reasonably provided by the arbitrator for good cause or as otherwise mutually agreed by the parties) be completed within 60 days of commencement of the hearings; and the arbitrator&#146;s award shall be made within 30 days following such
completion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.2&#8195;The arbitrator may award any form of relief permitted under this Agreement and applicable law, including damages
and temporary or permanent injunctive relief, except that the arbitral tribunal is not empowered to award damages in excess of compensatory damages, and each party hereby irrevocably waives any right to recover punitive, exemplary or similar damages
with respect to any dispute. The arbitrator shall have no jurisdiction to vary the express terms of this Agreement. The Company and Employee shall equally bear all costs, fees and expenses of the arbitration; <U>provided</U>, <U>however</U>, that
each party shall bear its own attorney&#146;s fees. The arbitrator may award attorney&#146;s fees. The award shall be in writing and shall state the reasons for the award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.3&#8195;The decision rendered by the arbitrator shall be final and binding on the parties and may be entered in any court of competent
jurisdiction. The parties waive, to the fullest extent permitted by law, any rights to appeal to, or to seek review of such award by, any court. The parties further agree to obtain the arbitral tribunal&#146;s agreement to preserve the
confidentiality of the arbitration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>14</B>&#8195;<B><U>Representations and Warranties</U></B>. Employee represents, warrants and
agrees that he has all right, power, authority and capacity, and is free to enter into this Agreement; that by doing so, Employee will not violate or interfere with the rights of any other person or entity; and that Employee is not subject to any
contract, understanding or obligation that will or might prevent, interfere or conflict with or impair the performance of this Agreement by Employee (including, but not limited to, any <FONT STYLE="white-space:nowrap">non-compete,</FONT> <FONT
STYLE="white-space:nowrap">non-solicitation</FONT> or confidentiality agreement with any former employer). Employee further represents, warrants, and agrees that he will not enter into any agreement or other obligation while this Agreement is in
effect that might conflict or interfere with the operation of this Agreement or his obligations hereunder. Employee agrees to indemnify and hold the Company harmless with respect to any losses, liabilities, demands, claims, fees, expenses, damages
and costs (including attorneys&#146; fees and costs) resulting from or arising out of any claim or action based upon Employee&#146;s entering into this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>15</B>&#8195;<B><U>Waiver</U></B>. No waiver of any breach of any term of this Agreement shall be construed to be, nor shall be, a waiver
of any breach of this Agreement. No wavier shall be binding unless in writing and signed by the party waiving the breach. No course of conduct or failure or delay in enforcing the provisions of this Agreement shall affect the validity, binding
effect or enforceability of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 5 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>16</B>&#8195;<B><U>Modification</U></B>. Neither this Agreement nor the provisions
contained herein may be extended, renewed, amended or modified other than by a written agreement executed by Employee and the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17</B>&#8195;<B><U>Construction</U></B>. The rule that a contract is construed against the party drafting the contract is hereby waived,
and shall have no applicability in construing this Agreement or the terms hereof. Any headings and captions used herein are only for convenience and shall not affect the construction or interpretation of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>18</B>&#8195;<B><U>Legal Representation</U></B>. The parties understand that this is a legally binding contract and acknowledge and agree
that they have had a reasonable opportunity to consult with legal counsel of their choice prior to execution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>19</B>&#8195;<B><U>Survival of Obligations.</U></B><B> </B>The parties expressly agree that Employee&#146;s obligations set forth in this
Agreement (and any exhibits attached hereto), as well as any other obligations that would naturally survive termination of an employment agreement, shall survive termination of Employee&#146;s employment (whether voluntary or involuntary and whether
with or without Cause and whether with or without Good Reason) and shall also survive the end of the term of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>20</B>&#8195;<B><U>Counterparts</U></B>. This Agreement may be executed in counterparts, each of which shall be deemed to be an original,
and all of which together shall constitute one and the same original instrument. A facsimile signature shall be deemed an original signature for purposes of execution of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>21</B>&#8195;<B><U>Section 409A of the Code</U></B>. Notwithstanding any provision of this Agreement to the contrary: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">21.1&#8195;All provisions of this Agreement are intended to comply with Section&nbsp;409A of the Internal Revenue Code of 1986 (as amended, the
&#147;<B><I>Code</I></B>&#148;) and the applicable Department of Treasury regulations and administrative guidance issued thereunder (collectively, &#147;<B><I>Section</I></B><B><I></I></B><B><I>&nbsp;409A</I></B>&#148;) or an exemption therefrom and
shall be construed and administered in accordance with such intent. Any payments under this Agreement that may be excluded from Section&nbsp;409A either as separation pay due to an involuntary separation from service or as a short-term deferral
shall be excluded from Section&nbsp;409A to the maximum extent possible. For purposes of Section&nbsp;409A, each installment payment provided under this Agreement shall be treated as a separate payment. Any payments to be made under this Agreement
upon a termination of Employee&#146;s employment shall only be made if such termination of employment constitutes a &#147;separation from service&#148; under Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">21.2&#8195;To the extent that any right to reimbursement of expenses or payment of any benefit <FONT STYLE="white-space:nowrap">in-kind</FONT>
under this Agreement constitutes nonqualified deferred compensation (within the meaning of Section&nbsp;409A), (a) any such expense reimbursement shall be made by the Company no later than the last day of Employee&#146;s taxable year following the
taxable year in which such expense was incurred by Employee, (b)&nbsp;the right to reimbursement or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits shall not be subject to liquidation or exchange for another benefit and (c)&nbsp;the amount
of expenses eligible for reimbursement or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits provided during any taxable year shall not affect the expenses eligible for reimbursement or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits
to be provided in any other taxable year; <U>provided</U> that, the foregoing clause shall not be violated with regard to expenses reimbursed under any arrangement covered by Section&nbsp;105(b) of the Code solely because such expenses are subject
to a limit related to the period in which the arrangement is in effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 6 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">21.3&#8195;If any payment or benefit provided for herein would be subject to additional
taxes and interest under Section&nbsp;409A if Employee&#146;s receipt of such payment or benefit is not delayed until the earlier of (a)&nbsp;the date of Employee&#146;s death or (b)&nbsp;the date that is six months after the Termination Date (such
date, the &#147;<B><I>Section</I></B><B><I></I></B><B><I>&nbsp;409A Payment Date</I></B>&#148;), then such payment or benefit shall not be provided to Employee (or Employee&#146;s estate, if applicable) until the Section&nbsp;409A Payment Date.
Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under this Agreement are exempt from, or compliant with, Section&nbsp;409A and in no event shall the Company be liable for all or any portion
of any taxes, penalties, interest or other expenses that may be incurred by Employee on account of <FONT STYLE="white-space:nowrap">non-compliance</FONT> with Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">* * * * * </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Signature Page
Follows </I></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 7 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the Effective
Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>WALGREENS BOOTS ALLIANCE, INC.</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stefano Pessina</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Stefano Pessina</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Its:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Executive Chairman</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>TIMOTHY C. WENTWORTH</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><B>/s/ Timothy C. Wentworth</B></P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Signature Page to
Employment Agreement </I></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WALGREENS BOOTS ALLIANCE, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">NON-COMPETITION,</FONT> <FONT STYLE="white-space:nowrap">NON-SOLICITATION</FONT> AND CONFIDENTIALITY
AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This Agreement (the &#147;<B><I><FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement</I></B>&#148;) is entered
into this 9th day of October, 2023 (the &#147;<B><I>Effective Date</I></B>&#148;), by the undersigned employee, Timothy C. Wentworth (&#147;<B><I>Employee</I></B>&#148; or &#147;<B><I>I</I></B>&#148;), and Walgreens Boots Alliance, Inc., a Delaware
corporation, on behalf of itself, its affiliates, subsidiaries, successors and assigns (collectively referred to as the &#147;<B><I>Company</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company develops and/or uses valuable business, technical, proprietary, customer and patient information it protects by limiting
its disclosure and by keeping it secret or confidential; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, Employee acknowledges that during the course of employment, he or she
has or will receive, contribute, or develop such Confidential Information and Trade Secrets (as defined below); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company
desires to protect from third parties (e.g. competitors and customers) such Confidential Information and Trade Secrets and also desires to protect its legitimate business interests and goodwill in maintaining its employee and customer relationships.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">NOW THEREFORE, for good and valuable consideration, including but not limited to employment or continued employment, new or additional
compensation in connection with Employee&#146;s hire or promotion, the specialized knowledge, skill and training that the Company provides Employee, and the goodwill that Employee develops with customers on behalf of the Company, Employee agrees to
be bound by the terms of this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement as follows: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.&#8195;<U>Confidentiality</U>.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;At all times during and after the termination of my employment with the Company, I will not, without the
Company&#146;s prior written permission, directly or indirectly for any purpose other than performance of my duties for the Company, utilize or disclose to anyone outside of the Company any Trade Secrets (defined in subparagraph 1(a)(i)) or other
Confidential Information (defined in subparagraph 1(a)(ii)) or any information received by the Company in confidence from or about third parties, as long as such matters remain Trade Secrets or otherwise confidential. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&#8195;For purposes of this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement, &#147;<B><I>Trade
Secrets</I></B>&#148; means a form of intellectual property that are protectable under applicable state and/or Federal law, including the Uniform Trade Secrets Act (as amended and adapted by the states) and the Federal Defend Trade Secrets Act of
2016 (the &#147;<B><I>DTSA</I></B>&#148;). They include all tangible and intangible (<I>e.g.</I>, electronic) forms and types of information that is held and kept confidential by the Company and is not generally known outside of the Company,
including but not limited to information about: the Company&#146;s financial, business, scientific, technical, economic, or engineering information, including patterns, plans, compilations, program devices, formulas, designs, prototypes, methods,
techniques, processes, procedures, programs or codes, and may in particular include such things as pricing information, business records, software programs, algorithms, inventions, patent applications, and designs and processes not known outside the
Company. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&#8195;For purposes of this
<FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement, &#147;Confidential Information&#148; means Trade Secrets and, more broadly, any other tangible and intangible (e.g., electronic) forms and types of information that are held and kept
confidential by the Company and are not generally known outside the Company, and which relates to the actual or anticipated business of the Company or the Company&#146;s actual or prospective vendors or clients. Confidential Information shall not be
considered generally known to the public if is revealed improperly to the public by me or others without the Company&#146;s express written consent and/or in violation of an obligation of confidentiality to the Company. Examples of Confidential
Information include, but are not limited to: customer, referral source, supplier and contractor identification and contacts; special contract terms; pricing and margins; business, marketing and customer plans and strategies; financial data; company
created (or licensed) techniques; technical <FONT STYLE="white-space:nowrap">know-how;</FONT> research, development and production information; processes, prototypes, software, patent applications and plans, projections, proposals, discussion
guides, and/or personal or performance information about employees. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;I understand that this obligation of <FONT
STYLE="white-space:nowrap">non-disclosure</FONT> shall last so long as the information remains confidential. I, however, understand that, if I live and work primarily in Wisconsin, Virginia, or any other state&nbsp;requiring a temporal limit on <FONT
STYLE="white-space:nowrap">non-disclosure</FONT> clauses, Confidential Information shall be protected for two years following termination of my employment (for any reason).&nbsp;I also understand that Trade Secrets are protected by statute and are
not subject to any time limits.&nbsp;I also agree to contact the Company before using, disclosing, or distributing any Confidential Information or Trade Secrets if I have any questions about whether such information is protected information. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&#8195;The restrictions set forth in this paragraph are in addition to and not in lieu of any obligations or rights I have
by law with respect to the Company&#146;s Confidential Information. Consistent with subparagraph 9(n) below, nothing herein shall prohibit me from disclosing Confidential Information or Trade Secrets if compelled by order of court or an agency of
competent jurisdiction or as required by law; however, I shall take reasonable steps to protect such disclosure of Confidential Information or Trade Secrets. Pursuant to the Defend Trade Secrets Act of 2016 (DTSA), I understand that an individual
may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a Trade Secret that: (A)&nbsp;is made (i)&nbsp;in confidence to a federal, state or local government official, either directly or
indirectly, or to an attorney, and (ii)&nbsp;solely for the purpose of reporting or investigating a suspected violation of law; or (B)&nbsp;is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under
seal. Additionally, I understand that an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the Trade Secret to his or her attorney and use the Trade Secret information in the court
proceeding, so long as any document containing the Trade Secret is filed under seal and the individual does not disclose the Trade Secret, except pursuant to court order. Nothing in this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement
is intended to conflict with the DTSA or create liability for disclosures of Trade Secrets that are expressly allowed by DTSA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.&#8195;<U><FONT STYLE="white-space:nowrap">Non-Competition</FONT></U>. I agree that during my employment with the Company and for two years
after the termination of my employment (for any reason), I will not, directly or indirectly have Responsibilities with respect to any Competing Business Line. As set forth in subparagraph 9(b) below, I understand that the restrictions in this
paragraph apply no matter whether my employment </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
is terminated by me or the Company and no matter whether that termination is voluntary or involuntary. These restrictions shall not apply to passive investments of less than 5% ownership interest
in any entity. For purposes of this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement, &#147;<B><I>Responsibilities</I></B>&#148; means the same or similar material responsibilities I performed for the Company during the two years prior
to my last day of employment with the Company and within the same geographic area, or portion thereof, where I performed those responsibilities for the Company. For purposes of this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement,
&#147;<B><I>Competing Business Line</I></B>&#148; means any business that is in competition with any business engaged in by the Company and for which I had Responsibilities during the two years prior to my last day of employment with the Company.
Competing Business Line shall also include businesses or business lines that may not be directly competitive with the Company in most respects (such as pharmacy benefit managers), but only to the extent I am engaged by any such business in a role:
(a)&nbsp;that involves my performing Responsibilities for Competing Products or Services; or (b)&nbsp;where my knowledge of the Company&#146;s Confidential Information could be used by a competitor to unfairly compete with or undermine the
Company&#146;s legitimate business interests. For purposes of this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement, &#147;<B><I>Competing Products or Services</I></B>&#148; means products or services that are competitive with products
or services offered by, developed by, designed by or distributed by the Company during the two years prior to my last day of employment with the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.&#8195;<U><FONT STYLE="white-space:nowrap">Non-Solicitation</FONT></U>. I agree that during my employment with the Company and for two years
after the termination of my employment from the Company (for any reason): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;I will not directly or indirectly,
solicit any Restricted Customer for purposes of providing Competing Products or Services, or offer, provide or sell Competing Products or Services to any Restricted Customer. For purposes of this <FONT STYLE="white-space:nowrap">Non-Compete</FONT>
Agreement, &#147;<B><I>Restricted Customer</I></B>&#148; means any person, company or entity that was a customer, vendor, supplier or referral source of the Company and with which I had direct contact for purposes of performing responsibilities for
the Company or for which I had supervisory responsibilities on behalf of the Company, in either case at any time during the two years prior to my last day of employment with the Company. To the extent permitted by applicable law, &#147;Restricted
Customer&#148; also means any prospective customer(s), vendor(s), supplier(s) or referral source(s) with which I had business contact on behalf of the Company in the one year period immediately prior to my last day of employment with the Company;
and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;I will not, nor will I assist any third party to, directly or indirectly (i)&nbsp;raid, solicit, or attempt
to persuade any then-current employee of the Company with whom I currently directly work or with whom I had direct contact work during the two years prior to my last day of employment with the Company, and who possesses or had access to Confidential
Information of the Company, to leave the employ of the Company; (ii)&nbsp;interfere with the performance by any such employee of his/her duties for the Company; and/or (iii)&nbsp;communicate with any such employee for the purposes described in items
(i)&nbsp;and (ii) in this subparagraph 3(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.&#8195;<U><FONT STYLE="white-space:nowrap">Non-Inducement</FONT></U>. I will not directly
or indirectly assist or encourage any person or entity in carrying out or conducting any activity that would be prohibited by this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement if such activity were carried out or conducted by me.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.&#8195;<U><FONT STYLE="white-space:nowrap">Non-Disparagement</FONT></U>. During my employment with the Company and thereafter, I agree
not to make negative comments or otherwise disparage the Company or any of its officers, directors, employees, shareholders, members, agents or products. The foregoing shall not be violated by truthful statements in response to legal process,
required governmental testimony or filings, or administrative or arbitral proceedings (including, without limitation, depositions in connection with such proceedings); and the foregoing shall not apply to any claims for harassment or discrimination
to the extent so restricted by applicable state law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.&#8195;<U>Intellectual Property</U>. The term &#147;<B><I>Intellectual
Property</I></B>&#148; shall mean all trade secrets, ideas, inventions, designs, developments, devices, software, computer programs, methods and processes (whether or not patented or patentable, reduced to practice or included in the Confidential
Information) and all patents and patent applications related thereto, all copyrights, copyrightable works and mask works (whether or not included in the Confidential Information) and all registrations and applications for registration related
thereto, all Confidential Information, and all other proprietary rights contributed to, or conceived or created by, or reduced to practice by me or anyone acting on my behalf (whether alone or jointly with others) at any time from the beginning of
my employment with the Company to the termination of that employment plus 90 days, that (i)&nbsp;relate to the business or to the actual or anticipated research or development of the Company; (ii)&nbsp;result from any services that I or anyone
acting on my behalf perform for the Company; or (iii)&nbsp;are created using the equipment, supplies or facilities of the Company or any Confidential Information. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;<U>Ownership</U>. All Intellectual Property is, shall be and shall remain the exclusive property of the Company. I
hereby assign to the Company all right, title and interest, if any, in and to the Intellectual Property; provided, however, that, when applicable, the Company shall own the copyrights in all copyrightable works included in the Intellectual Property
pursuant to the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;work-made-for-hire&#148;</FONT></FONT> doctrine (rather than by assignment), as such term is defined in the 1976 Copyright Act. All Intellectual Property shall
be owned by the Company irrespective of any copyright notices or confidentiality legends to the contrary that may be placed on such works by me or by others. I shall ensure that all copyright notices and confidentiality legends on all work product
authored by me or anyone acting on his/her behalf shall conform to the Company&#146;s practices and shall specify the Company as the owner of the work. The Company hereby provides notice to me that the obligation to assign does not apply to an
invention for which no equipment, supplies, facility, or Trade Secrets of the Company was used and which was developed entirely on my own time, unless (i)&nbsp;the invention relates (A)&nbsp;to the business of the Company, or (B)&nbsp;to the
Company&#146;s actual or demonstrably anticipated research or development, or (ii)&nbsp;the invention results from any work performed by me for the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;<U>Keep Records</U>. I shall keep and maintain, or cause to be kept and maintained by anyone acting on my behalf,
adequate and current written records of all Intellectual Property in the form of notes, sketches, drawings, computer files, reports or other documents relating thereto. Such records shall be and shall remain the exclusive property of the Company and
shall be available to the Company at all times during my employment with the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&#8195;<U>Assistance</U>. I shall
supply all assistance requested in securing for the Company&#146;s benefit any patent, copyright, trademark, service mark, license, right or other evidence of ownership of any such Intellectual Property, and will provide full information regarding
any such item and execute all appropriate documentation prepared by Company in applying or otherwise registering, in the Company&#146;s name, all rights to any such item or the defense and protection of such Intellectual Property. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&#8195;<U>Prior Inventions</U>. I have disclosed to the Company any continuing obligations to any third party with respect
to Intellectual Property. I claim no rights to any inventions created prior to his/her employment for which a patent application has not previously been filed, unless he/she has described them in detail on a schedule attached to this <FONT
STYLE="white-space:nowrap">Non-Compete</FONT> Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&#8195;<U>Trade Secret Provisions</U>. The provisions in paragraph 1 of
this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement with regard to Trade Secrets and the DTSA shall apply as well in the context of the parties&#146; Intellectual Property rights and obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.&#8195;<U>Return of Company Property</U>. I agree that all documents and data accessible to me during my employment with the Company,
including Confidential Information and Trade Secrets, regardless of format (electronic or hard copy), including but not limited to any Company computer, monitor, printer equipment, external drives, wireless access equipment, telecom equipment and
systems (&#147;<B><I>Company Equipment</I></B>&#148;), are and remain the sole and exclusive property of the Company and/or its clients, and must be returned to the Company upon separation or upon demand by the Company. I further agree that I will
provide passwords to access such Company Equipment and I will not print, retain, copy, destroy, modify or erase Company U.S. data on Company Equipment or otherwise wipe Company Equipment prior to returning the Company Equipment. I further
acknowledge and agree that, beginning on my last day of employment, (a)&nbsp;I shall remove any reference to the Company as my current employer from any source I control, either directly or indirectly, including, but not limited to, any social
media, including LinkedIn, Facebook, Twitter, Instagram, Google+, and/or MySpace, etc. and (b)&nbsp;I am not permitted to represent that I am currently being employed by the Company to any person or entity, including, but not limited to, on any
social media. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.&#8195;<U>Consideration and Acknowledgments</U>. I acknowledge and agree that the covenants described in this <FONT
STYLE="white-space:nowrap">Non-Compete</FONT> Agreement are essential terms, and the underlying consideration would not be provided by the Company in the absence of these covenants. I further acknowledge that these covenants are supported by
adequate consideration as set forth in this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement and are not in conflict with any public interest. I further acknowledge and agree that I fully understand these covenants, have had full and
complete opportunity to discuss and resolve any ambiguities or uncertainties regarding these covenants before signing this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement, and have voluntarily agreed to comply with these covenants for
their stated terms. I further acknowledge and agree that these covenants are reasonable and enforceable in all respects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.&#8195;<U>Enforceability; General Provisions</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&#8195;I understand that my <FONT STYLE="white-space:nowrap">non-compete</FONT> and/or
<FONT STYLE="white-space:nowrap">non-solicitation</FONT> obligations in this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement shall not apply to me if I am covered under applicable state or local statutory law prohibiting <FONT
STYLE="white-space:nowrap">non-competes</FONT> or <FONT STYLE="white-space:nowrap">non-solicits</FONT> on the basis of my income and/or position level at the time of enforcement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&#8195;I agree that the restrictions contained in this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement are
reasonable and necessary to protect the Company&#146;s legitimate business interests and that full compliance with the terms of this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement will not prevent me from earning a livelihood
following the termination of my employment, and that these covenants do not place undue restraint on me. I further understand that the restrictions in this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement apply no matter whether my
employment is terminated by me or the Company and no matter whether that termination is voluntary or involuntary. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&#8195;Because the Company is incorporated in the state of Delaware (i)&nbsp;this
<FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to any conflict of law provisions, and (ii)&nbsp;I consent
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
to personal jurisdiction and the exclusive jurisdiction of the state and federal courts of Delaware with respect to any claim, dispute or declaration arising out of this <FONT
STYLE="white-space:nowrap">Non-Compete</FONT> Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&#8195;In the event of a breach or a threatened breach of this
<FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement, I acknowledge that the Company will face irreparable injury which may be difficult to calculate in dollar terms and that the Company shall be entitled, in addition to all remedies
otherwise available in law or in equity, to temporary restraining orders and preliminary and final injunctions enjoining such breach or threatened breach in any court of competent jurisdiction without the necessity of posting a surety bond, as well
as to obtain an equitable accounting of all profits or benefits arising out of any violation of this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&#8195;I agree that if a court determines that any of the provisions in this
<FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement is unenforceable or unreasonable in duration, territory, or activity, then that court shall modify those provisions so they are reasonable and enforceable, and enforce those provisions as
modified. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&#8195;If any one or more provisions (including paragraphs, subparagraphs and terms) of this <FONT
STYLE="white-space:nowrap">Non-Compete</FONT> Agreement or its application is determined to be invalid, illegal, or unenforceable to any extent or for any reason by a court of competent jurisdiction, I agree that the remaining provisions (including
paragraphs, subparagraphs and terms) of this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement will still be valid and the provision declared to be invalid or illegal or unenforceable will be considered to be severed and deleted from the
rest of this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement. I further agree that if any court of competent jurisdiction finds any of the restrictions set forth in this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement to
be overly broad and unenforceable, the restriction shall be interpreted to extend only over the maximum time period, geographic area, or range of activities or clients that such court deems enforceable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&#8195;Notwithstanding the foregoing provisions of this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement, the <FONT
STYLE="white-space:nowrap">non-competition</FONT> provisions of paragraph 2 above shall not restrict me from performing legal services as a licensed attorney for a Competing Business Line to the extent that the attorney licensure requirements in the
applicable jurisdiction do not permit me to agree to the otherwise applicable restrictions of paragraph 2. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&#8195;Waiver of any of the provisions of this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement by the Company
in any particular instance shall not be deemed to be a waiver of any provision in any other instance and/or of the Company&#146;s other rights at law or under this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&#8195;I agree that the Company may assign this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement to its
successors and assigns and that any such successor or assign may stand in the Company&#146;s stead for purposes of enforcing this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&#8195;I agree to reimburse the Company for all attorneys&#146; fees, costs, and expenses that it reasonably incurs in
connection with enforcing its rights and remedies under this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement, but only to the extent the Company is ultimately the prevailing party in the applicable legal proceedings. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)&#8195;I understand and agree that, where allowed by applicable law, the time for my obligations set out in <FONT
STYLE="white-space:nowrap">paragraphs&nbsp;2-6</FONT> shall be extended for period of <FONT STYLE="white-space:nowrap">non-compliance</FONT> up to an additional two years following my last day of employment with the Company (for any reason). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l)&#8195;I fully understand my obligations in this <FONT
STYLE="white-space:nowrap">Non-Compete</FONT> Agreement, have had full and complete opportunity to discuss and resolve any ambiguities or uncertainties regarding these covenants before signing this <FONT STYLE="white-space:nowrap">Non-Compete</FONT>
Agreement, and have voluntarily agreed to comply with these covenants for their stated terms. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m)&#8195;I agree that all <FONT
STYLE="white-space:nowrap">non-competition,</FONT> <FONT STYLE="white-space:nowrap">non-solicitation,</FONT> <FONT STYLE="white-space:nowrap">non-disclosure</FONT> and use, <FONT STYLE="white-space:nowrap">non-recruiting,</FONT> and disclosure
obligations in this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement shall survive any termination of this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement and extend to the proscribed periods following my last day of
employment with the Company (for any reason) and no dispute regarding any other provisions of this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement or regarding my employment or the termination of my employment shall prevent the
operation and enforcement of these obligations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n)&#8195;I understand that nothing in this
<FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement, including the <FONT STYLE="white-space:nowrap">non-disclosure</FONT> and <FONT STYLE="white-space:nowrap">non-disparagement</FONT> provisions, limit my ability to file a charge or
complaint with the Equal Employment Opportunity Commission, Department of Labor, National Labor Relations Board, Occupational Safety and Health Administration, Securities and Exchange Commission or any other federal, state or local governmental
agency or commission. I also understand that this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement does not limit my ability to communicate with any government agencies or otherwise participate in any investigation or proceeding that
may be conducted by any government agency, including providing documents or other information, without notice to the Company.&nbsp;Finally, nothing in this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement in any way prohibits or is
intended to restrict or impede, and shall not be interpreted or understood as restricting or impeding me from: (i)&nbsp;exercising my rights under Section&nbsp;7 of the National Labor Relations Act (NLRA) (including with respect to engaging in
concerted activities for the purpose of collective bargaining or other mutual aid or protection, discussing terms and conditions of employment, or otherwise engaging in protected conduct); or (ii)&nbsp;otherwise disclosing or discussing truthful
information about unlawful employment practices (including unlawful discrimination, harassment, retaliation, or sexual assault). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.&#8195;<U>Relationship of Parties</U>. I acknowledge that my relationship with the Company is &#147;terminable at will&#148; by either
party and that the Company or I can terminate the relationship with or without cause and without following any specific procedures. Nothing contained in this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement is intended to or shall be
relied upon to alter the &#147;terminable at will&#148; relationship between the parties. I agree that my obligations in this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement shall survive the termination of my employment from the
Company for any reason and shall be binding upon my successors, heirs, executors and representatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.&#8195;<U>Modifications and
Other Agreements</U>. I agree that the terms of this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement may not be modified except by a written agreement signed by both me and the Company. This
<FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement shall not supersede any other restrictive covenants to which I may be subject under an employment contract, benefit program or otherwise, such that the Company may enforce the terms of
any and all restrictive covenants to which I am subject. The obligations herein are in addition to and do not limit any obligations arising under applicable statutes and common law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.&#8195;<U>Notification</U>. I agree that in the event I am offered employment at any time
in the future with any entity that may be considered a Competing Business Line, I shall immediately notify such Competing Business Line of the existence and terms of this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement. I also
understand and agree that the Company may notify anyone attempting to or later employing me of the existence and provisions of this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.&#8195;<U>Acceptance and Change of Position</U>. I agree that this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement is
accepted by me through my original or facsimile signature. I further agree that the Company is deemed to have accepted this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement as evidenced by my employment, the payment of wages or monies
to me, the provision of benefits to me, or by executing this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement. I acknowledge and agree that any change in my position or title with the Company shall not cause this <FONT
STYLE="white-space:nowrap">Non-Compete</FONT> Agreement to terminate and shall not affect any change in my obligations under this <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">* * * * * </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Signature Page
Follows </I></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">By my signature below, I agree to the terms and conditions expressed in this <FONT
STYLE="white-space:nowrap">Non-Compete</FONT> Agreement as of the Effective Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>WALGREENS BOOTS ALLIANCE, INC.</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stefano Pessina</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Stefano Pessina</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Its:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Executive Chairman</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>TIMOTHY C. WENTWORTH</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><B>/s/ Timothy C. Wentworth</B></P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Signature Page to
Exhibit A to Employment Agreement </I></P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d559360dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g559360g1010185159390.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt;margin-bottom:0pt; text-indent:8%">


<IMG SRC="g559360g1010185159748.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Walgreens Boots Alliance Appoints Tim Wentworth as Chief Executive Officer</B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Mr.&nbsp;Wentworth brings nearly three decades of healthcare leadership experience to WBA </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DEERFIELD, Ill., Oct. 10, 2023&#151;Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the appointment of Tim Wentworth as the company&#146;s new
Chief Executive Officer, effective on October 23. Mr.&nbsp;Wentworth will also join the WBA Board of Directors upon assuming the role.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Most recently, as
founding CEO of Evernorth, Cigna&#146;s health services organization that partners with health plans, employers and government organizations, Mr.&nbsp;Wentworth brought together health service capabilities including care provision, pharmacy
solutions and benefits management. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to Cigna, Mr.&nbsp;Wentworth was CEO of Express Scripts, the largest pharmacy benefit manager in the United
States, following the company&#146;s merger with Medco Health Solutions, Inc. in&nbsp;April 2012. He grew it into a Fortune 22 company with more than $100&nbsp;billion in revenue and 26,000 employees, also ranking number 66 on Forbes Magazine&#146;s
list of the World&#146;s Most Innovative Companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Previously, he led Medco&#146;s employer and key accounts organizations for nearly 14 years, also
serving as President and CEO of Accredo, Medco&#146;s specialty pharmacy. Prior to joining Medco, Mr.&nbsp;Wentworth spent five years at Mary Kay, Inc., where he initially served as Senior Vice President of Human Resources and later, President of
its international business. He also held roles of increasing responsibility over nine years in human resources management at PepsiCo. He has an associate&#146;s degree in business from&nbsp;Monroe Community College&nbsp;and a bachelor&#146;s degree
in industrial and labor relations from&nbsp;Cornell University. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Wentworth joins WBA at a pivotal time, as the company focuses on <FONT
STYLE="white-space:nowrap">right-sizing</FONT> the business, while driving execution and creating greater value for employees, patients, customers and shareholders.&nbsp;WBA&#146;s goal is to be the independent partner of choice, not just in
pharmacy but also in healthcare services where it can improve healthcare, lower costs, and help patients. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The WBA Board has been focused on
bringing in a CEO with deep healthcare experience, and we are pleased to welcome Tim Wentworth as the company&#146;s new CEO. He is an accomplished and respected leader&nbsp;with profound expertise in the payer and pharmacy space as well as supply
chain, IT and Human Resources. We are confident he is the right person to lead WBA&#146;s next phase of growth into a customer-centric healthcare company,&#148; said Stefano Pessina, Executive Chairman, WBA. &#147;I look forward to working with Tim,
as well as the rest of the Board and WBA leadership, to lead WBA into a successful future. I also want to thank Ginger Graham for her leadership and immense commitment to our people and operations during this interim period. We look forward to
welcoming her back as the Board&#146;s Lead Independent Director.&#148;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;I am honored and excited for the incredible opportunity to lead the next phase of WBA&#146;s
evolution, working with the Board and WBA leadership to deliver sustainable value and results. WBA has a differentiated model with the power to build on the company&#146;s pharmacy strength and trusted brand to evolve healthcare delivery.&nbsp;I
believe in WBA&#146;s vision to be the leading partner in reimagining local healthcare and well-being for all,&#148; said Mr.&nbsp;Wentworth.&nbsp;&#147;I&#146;ve spent my career working to improve the health of the patients we&#146;ve served. I
believe WBA is well-positioned to deliver more personalized, coordinated care, and achieve better outcomes at a lower cost. I fully recognize the challenges that health plans, healthcare providers, pharmacies, and retailers are confronting today and
am confident that WBA, and its customer- and patient-focused teams, can seize the opportunities of a dynamic marketplace and be the partner of choice.&#148;</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Walgreens Boots Alliance</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Walgreens Boots Alliance
(Nasdaq: WBA) is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a <FONT STYLE="white-space:nowrap">170-year</FONT> heritage of caring for communities.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A trusted, global innovator in retail pharmacy with approximately 13,000 locations across the U.S., Europe and Latin America, WBA plays a critical role in the
healthcare ecosystem. The company is reimagining local healthcare and well-being for all as part of its purpose &#150; to create more joyful lives through better health. Through dispensing medicines, improving access to a wide range of health
services, providing high quality health and beauty products and offering anytime, anywhere convenience across its digital platforms, WBA is shaping the future of healthcare.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WBA employs more than 331,000 people and has a presence in nine countries through its portfolio of consumer brands: Walgreens, Boots, Duane Reade, the No7
Beauty Company, Benavides in Mexico and Ahumada in Chile. Additionally, WBA has a portfolio of healthcare-focused investments located in several countries, including China and the U.S.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The company is proud of its contributions to healthy communities, a healthy planet, an inclusive workplace and a sustainable marketplace. WBA has been
recognized for its commitment to being an inclusive workplace. In fiscal 2023, the Company received a score of 100 from the Human Rights Campaign&#146;s Corporate Equality Index, scored 100&nbsp;percent on the Disability Equality Index for
disability inclusion and was named Disability:IN&#146;s 2023 Employer of the Year. In addition, WBA has been recognized for its commitment to operating sustainably as the company is an index component of the Dow Jones Sustainability Indices
(DJSI).</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">More company information is available at <U>www.walgreensbootsalliance.com</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Cautionary Note Regarding Forward-Looking Statements: All statements in this release and related conference and webcast that are not historical are
forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and
uncertainties, including those described in Item 1A (Risk Factors) of our Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended August&nbsp;31, 2022 and in other documents that we file or furnish with the Securities and
Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
incorrect, actual results may vary materially. These forward-looking statements speak only as of the date they are made. We do not undertake, and expressly disclaim, any duty or obligation to
update publicly any forward-looking statement after the date of this release, whether as a result of new information, future events, changes in assumptions or otherwise. </I></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I># # #</I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>WBA Media Relations</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Contact</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">USA / Jim Cohn</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">+1 224 813 9057</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">International</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">+44&nbsp;(0)20&nbsp;7980&nbsp;8585</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>WBA Investor Relations</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Contact</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Tiffany Kanaga</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">+1 847 315 2922</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>wba-20231010.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 10/11/2023 9:39:49 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:wba="http://walgreensbootsalliance.com/20231010"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://walgreensbootsalliance.com/20231010"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" namespace="http://fasb.org/us-types/2022" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wba-20231010_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wba-20231010_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wba-20231010_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="wba_DocumentAndEntityInformationTable" name="DocumentAndEntityInformationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="wba_DocumentAndEntityInformationLineItems" name="DocumentAndEntityInformationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member" name="M3.600WalgreensBootsAllianceInc.NotesDue2025Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member" name="M2.125WalgreensBootsAllianceInc.NotesDue2026Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>wba-20231010_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 10/11/2023 9:39:51 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="wba-20231010.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="wba-20231010.xsd#wba_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="wba_DocumentAndEntityInformationTable" />
    <link:loc xlink:href="wba-20231010.xsd#wba_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="wba_DocumentAndEntityInformationLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="wba-20231010.xsd#wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member" xlink:type="locator" xlink:label="wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member" />
    <link:loc xlink:href="wba-20231010.xsd#wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member" xlink:type="locator" xlink:label="wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="wba_DocumentAndEntityInformationTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wba_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="23.0001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member" order="25" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member" order="26" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="28.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="29.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="33.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="34.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="35.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="36.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="37.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="38.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="39.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="40.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="41.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="42.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="43.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="44.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="45.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="46.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="47.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="48.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="49.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="50.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="51.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="52.001" priority="2" use="optional" />
  </link:definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>wba-20231010_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 10/11/2023 9:39:49 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="wba-20231010.xsd#wba_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="wba_DocumentAndEntityInformationTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wba_DocumentAndEntityInformationTable" xlink:to="wba_DocumentAndEntityInformationTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="wba_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="wba_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Table]</link:label>
    <link:loc xlink:href="wba-20231010.xsd#wba_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="wba_DocumentAndEntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="wba_DocumentAndEntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="wba_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="wba_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
    <link:loc xlink:href="wba-20231010.xsd#wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member" xlink:type="locator" xlink:label="wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member" xlink:to="wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">M 3.600 Walgreens Boots Alliance Inc . Notes Due 2025 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">M 3.600 Walgreens Boots Alliance Inc . Notes Due 2025 [Member]</link:label>
    <link:loc xlink:href="wba-20231010.xsd#wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member" xlink:type="locator" xlink:label="wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member" xlink:to="wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">M 2.125 Walgreens Boots Alliance Inc . Notes Due 2026 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">M 2.125 Walgreens Boots Alliance Inc . Notes Due 2026 [Member]</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>wba-20231010_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 10/11/2023 9:39:50 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="wba-20231010.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="wba-20231010.xsd#wba_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="wba_DocumentAndEntityInformationTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="wba_DocumentAndEntityInformationTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="wba-20231010.xsd#wba_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="wba_DocumentAndEntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationTable" xlink:to="wba_DocumentAndEntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="wba-20231010.xsd#wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member" xlink:type="locator" xlink:label="wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="wba-20231010.xsd#wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member" xlink:type="locator" xlink:label="wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="48.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="49.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="50.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="51.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="52.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g559360g1010185159390.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g559360g1010185159390.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !% 18# 2(  A$! Q$!_\0
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G "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g559360g1010185159748.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g559360g1010185159748.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  A +@# 2(  A$! Q$!_\0
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M52-"YNX[5H0X8^:X1<#N:GK)U1UE.FR(<JUPI!]JLWUZ\#Q6]O&LES+G8K'
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140651391696384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 10, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wba_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001618921<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 10,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">WALGREENS BOOTS ALLIANCE, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-1758322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">108 Wilmot Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Deerfield<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">60015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(847)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">315-2500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wba_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">WBA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member', window );">M 3.600 Walgreens Boots Alliance Inc . Notes Due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wba_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">3.600% Walgreens Boots Alliance, Inc. notes due 2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">WBA25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member', window );">M 2.125 Walgreens Boots Alliance Inc . Notes Due 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wba_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">2.125% Walgreens Boots Alliance, Inc. notes due 2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">WBA26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wba_DocumentAndEntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wba_DocumentAndEntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wba_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>d559360d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:wba="http://walgreensbootsalliance.com/20231010"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="wba-20231010.xsd" xlink:type="simple"/>
    <context id="duration_2023-10-10_to_2023-10-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001618921</identifier>
        </entity>
        <period>
            <startDate>2023-10-10</startDate>
            <endDate>2023-10-10</endDate>
        </period>
    </context>
    <context id="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001618921</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-10</startDate>
            <endDate>2023-10-10</endDate>
        </period>
    </context>
    <context id="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_wba-M3.600WalgreensBootsAllianceInc.NotesDue2025Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001618921</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wba:M3.600WalgreensBootsAllianceInc.NotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-10</startDate>
            <endDate>2023-10-10</endDate>
        </period>
    </context>
    <context id="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_wba-M2.125WalgreensBootsAllianceInc.NotesDue2026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001618921</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wba:M2.125WalgreensBootsAllianceInc.NotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-10</startDate>
            <endDate>2023-10-10</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2023-10-10_to_2023-10-10">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-10-10_to_2023-10-10"
      id="Hidden_dei_EntityCentralIndexKey">0001618921</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-10-10_to_2023-10-10">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-10-10_to_2023-10-10">2023-10-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2023-10-10_to_2023-10-10">WALGREENS BOOTS ALLIANCE, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-10-10_to_2023-10-10">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-10-10_to_2023-10-10">001-36759</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-10-10_to_2023-10-10">47-1758322</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-10-10_to_2023-10-10">108 Wilmot Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-10-10_to_2023-10-10">Deerfield</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-10-10_to_2023-10-10">IL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-10-10_to_2023-10-10">60015</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-10-10_to_2023-10-10">(847)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-10-10_to_2023-10-10">315-2500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-10-10_to_2023-10-10">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-10-10_to_2023-10-10">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-10-10_to_2023-10-10">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-10-10_to_2023-10-10">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">WBA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_wba-M3.600WalgreensBootsAllianceInc.NotesDue2025Member">3.600% Walgreens Boots Alliance, Inc. notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_wba-M3.600WalgreensBootsAllianceInc.NotesDue2025Member">WBA25</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_wba-M3.600WalgreensBootsAllianceInc.NotesDue2025Member">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_wba-M2.125WalgreensBootsAllianceInc.NotesDue2026Member">2.125% Walgreens Boots Alliance, Inc. notes due 2026</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_wba-M2.125WalgreensBootsAllianceInc.NotesDue2026Member">WBA26</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-10-10_to_2023-10-10_us-gaap-StatementClassOfStockAxis_wba-M2.125WalgreensBootsAllianceInc.NotesDue2026Member">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-10-10_to_2023-10-10">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M 9LPKLC]8G&@?KB>BXR6MD]QC_Z";*3U&LA<@ Y9)V#I^O0HUQ\F7"UM/3^
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M^>&*,]@[VP_ ^PLHT^N)?3A>_+;1^P=02P,$%     @ VS!+5Y^@&_"Q @
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M\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @
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M&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ VS!+5P=!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " #;,$M7-Q^53>T    K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " #;,$M7F5R<(Q &  "<)P  $P
M        @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( -LP
M2U=W9ZZQ,04  .<8   8              " @0P(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " #;,$M7GZ ;\+$"  #B#   #0
M        @ %S#0  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( -LP2U>7BKL<
MP    !,"   +              "  4\0  !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( -LP2U<<.&7J/P$  #P"   /              "  3@1  !X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    " #;,$M7)!Z;HJT   #X 0  &@
M    @ &D$@  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M" #;,$M799!YDAD!  #/ P  $P              @ &)$P  6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     "0 ) #X"  #3%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d559360d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="d559360d8k.htm">d559360d8k.htm</File>
    <File>wba-20231010.xsd</File>
    <File>wba-20231010_def.xml</File>
    <File>wba-20231010_lab.xml</File>
    <File>wba-20231010_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="28">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d559360d8k.htm": {
   "nsprefix": "wba",
   "nsuri": "http://walgreensbootsalliance.com/20231010",
   "dts": {
    "inline": {
     "local": [
      "d559360d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "wba-20231010.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "wba-20231010_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "wba-20231010_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "wba-20231010_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 2,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2022": 2
   },
   "contextCount": 4,
   "entityCount": 1,
   "segmentCount": 3,
   "elementCount": 30,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 28
   },
   "report": {
    "R1": {
     "role": "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2023-10-10_to_2023-10-10",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d559360d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2023-10-10_to_2023-10-10",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d559360d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "wba_M3.600WalgreensBootsAllianceInc.NotesDue2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://walgreensbootsalliance.com/20231010",
     "localname": "M3.600WalgreensBootsAllianceInc.NotesDue2025Member",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "M 3.600 Walgreens Boots Alliance Inc . Notes Due 2025 [Member]",
        "terseLabel": "M 3.600 Walgreens Boots Alliance Inc . Notes Due 2025 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "wba_M2.125WalgreensBootsAllianceInc.NotesDue2026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://walgreensbootsalliance.com/20231010",
     "localname": "M2.125WalgreensBootsAllianceInc.NotesDue2026Member",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "M 2.125 Walgreens Boots Alliance Inc . Notes Due 2026 [Member]",
        "terseLabel": "M 2.125 Walgreens Boots Alliance Inc . Notes Due 2026 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommonStockMember",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "Security12bTitle",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "wba_DocumentAndEntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://walgreensbootsalliance.com/20231010",
     "localname": "DocumentAndEntityInformationLineItems",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Line Items]",
        "terseLabel": "Document And Entity Information [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CityAreaCode",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "TradingSymbol",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentType",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "wba_DocumentAndEntityInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://walgreensbootsalliance.com/20231010",
     "localname": "DocumentAndEntityInformationTable",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Table]",
        "terseLabel": "Document And Entity Information [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://walgreensbootsalliance.com//20231010/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001193125-23-253805-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-253805-xbrl.zip
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M(%;%@QY% L:"(1IV6 SV:$[]W@$HS)? ]!Q"9% IBX2_EVA3)6*I&$M%_\^
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M4*]>^[(FN\J1.P,%'J,55?0H1B8'C,T0*111DD551_$ =*R!:0?C.F</M1L
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MQ^38J,98L&KJYFRZ)G=W?2J)/#F><@5B$)-+!K/(, %!@R", S>)7>ET_:[
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M'8_QZI-',Y=3P#>2J163_P2&K2FY'9S[/FG8WS!-X :>%$3W5(WO)'^"6)9
MX^<[N+^JFS3K/@V.+!R[HLA]T=;5Y*J<X^722)BWW(X.ZP!&V] #8-2H$_['
M[AXJ,_3_ :_C=<K;I>6 [R6L3)P'M(4,/G%V"X9SDLKNA?XMT,.N.RL_0H\J
M#/D=SJ2C/R"[]*ZP>U[;ALPK]130JV'F@(9B6M6>+[IO[_=(FEO-1M,50TR?
MY^SR8E4>3U.9(LV CMI;H-#W5L2? K3V@=7\EDY@K>>JC"D ]VSGGYN:['US
MOB(_UQ7N!N3EL.]HL='$K6JX@+4_.2R3M*S SJX4DH.]9=.TQ+]RF$$)EJ.X
M")DYL@I,) WE:M1A9U%*-O\SJP4L'9EHUA3P0-< "!:EMDB:SAT%4R('O*%D
ML%$\38&US\03 Z2MX<7>;3.%)*3S'J49[45FYLZRN==;0O->9?N0(YU(.7@E
MZ"F5"MW# +2JTQP]3$X4P]IIGJQTWHO31RHA&6'/@CC#W09KDI-% %L(N80Q
M#? M)2GT?K2K=<(Q6 =LHC7ZX4#O>X=]<2"/.471+XM]?Y*Y<0S[ P42'H0Z
MXZ?26^-89:HD/JFG9YQLJ#/A%AB#W3)!AKB$1_4.)4@:Q?I6[0A[6'6'Y!.9
M.VC[%;J"4-,<#I:,J3,:PR&<E;64@J,#0BP!B0FC<E;%!$EQ][,;<ES! 6.A
M!RI+\0FNWD2>R^9:<!WA(^BTE# P5(%Q\V91.B/G\"2Z0I)Y^BE=C8.$.V@B
M.J"IPQ[D\\:+C'<?MGD??T8EK%1"(MB&O&;SNH>!:3&N1\D$ O:7-8DBLP#X
M&9P;O1(<-V&>Q:H!:&D1,9?K#J]?-J,UA,>_0)=ZZK@<9#]\F;_!/1!=C:HM
M&H0&9)FS>QTHP#\:.U]O4-;IQ2.'6I;C  BB*^!N>@G%]PI?5RD8-$A<*X.L
M^Z#C\:>%)<Z#<2859?4T#)"B40;_ELTEQS73"M<;%[<D-WF63G!^56-CRZ!]
MP]]XNG#0[/X5LN[#RO:Z=JW6KQ1Z(S!&2.HI>\9+U"A*Q<**&0<Q8PYD"=L0
MRG3](78IQ)=&3.UF"O?QA%6J3X6F4><Q(<I:(:X-*V2P3'7$3NOE>R/HV1K&
M+4GA]A"Y3(HBR?$^EAC!S*)867/0FQ@&J^ 0DD:@V08.*F>;RMV]>5T]R)E\
M9L_DT6=4S55PIM+9&,P'22^Z^8#V,1R7H*%OE(8F^BOOL2[2\)8^B!7+ML0:
M#UENL<$\-Y)!^+,B%1$FC[R>K"FR6-!Y*-O855\DG"D!3->=G/ N16X1VA 3
M!7[S7%%T0(R#?($.CN[KVR'DCK-<947,!TRS>A ?T661D9\='DG;2N*S?</T
MUXNL#F$4=D68 4RT'\DA3F=U3/H(TGW12K/IO F#,L.!-S-\Z&4!6B<%D^G
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MQK!C$VN-JR?D#:_3E*%"ZY+*E-RQG@%/HGH"X6P:*Q2S (69N*]V*Y-I-OP
M9TY..LMP,"L2CEUHC?X"_[ 3*'+[>%BE68.0%%C*I3(/&\^5!-:]((7E3Z2P
MG(J(8Y7.:]8S$* O<0+8B9I1N1;R5SNE[6#4E38F#@Q+2_!A>F ,J5HP3H@=
MN#^2D(INV]=8* N-,26(5,YN GHN7TDF];=/_-VU($7MG3A544EH)N(QV)"U
M]PMI+?:34XAIDD=E[@ZE"+D.4_-8QA6E#R#E+X9Y@"ZIM("BLBI/G_'^B":U
M!.*%\&YV@WW]?F?3"T)NW]Q$@_]VDY.R^4SIRB0'60'K9'H2-_0B[1LMQP['
M9-U3 ;79HI0SU#I>-O#)!;<R##I"#[ E]WJV)+*0R%2#YPLN%":^D"&8JC58
M>E'-2-"T7%:V3C2)9J /5)Q_6H.@*:@^G8L!8%3DN<K_:G*VE?B5AAL:%&89
M*U8.I.,&2P@$.A&?>*T$TI>G(*\D]OPYEI"KR9/&J*U<P2E+[/DSMB1LG;3$
MFNR8]B158CLFFI,5'\P1 P!^QN&B")6)Z707,_5VI45D);XOI@R_([] 7OA:
M*-QY)=#:VG*5(M,>J_!B&6^6I*._&TE@C-C.BHL*LUPG2JQ84S37%6<=X,40
MOYC",@!1^#.NVW#@4%:?D8AA3HKKW.0UZL.$K^Z0P]F8RR_W3V%OA@;Y!,1J
M0G[#Z1&UOOL!BE=W+3K/!8G9F"T>%ZFO[ML;8T6UTVP CU/VB!5=/X0 &BL#
M4"^%)$U9FP/!S-C=93X6.NU^@_" X(*86BX"RO(%&"H=>\>1P="1B@!C"'P9
M\\"4^D2%R$ %[7SEQ1LO0CLZ?P@3^(;26AB6O0B*,>6)]7(%PY@-=\*4<G34
ME0S%1!@N;K);S_Y^&!="MS;BK.5BQ$7]2,F2/G"V.=K&)XE.1[Y0@&LTFCZR
M4Y1M$1?/TUI)KG&HDXK%^(^C>123"YU< ; 00G]ED5!]IK//SX?-D!"X;54X
MN8[DUD"&+>5";,5XF+)T.HTKP_'WB\NMY$*!A9;(K91> =9PTF!IL6%18YBC
M[T!&5ZRI1A+_  X0.0YQ>002(Q>A':/KJ-!YU"DPV)3Y2*O$NB4DW6SS#:?0
M?\SU])RP2T*,#\*-^9QYD6_)$6XE@:ZLE\/;JIXT4)F<>S#L&=(UW^T<9[>8
M0Q_3OCT8.C5M9@^:#>'L)Q)6G?(T=ZE@3EBCU8E\8>&8]C+A"V:2@:4=2[V;
M#2OIE[FVX [\PJU9Z\'V=MI:].1IN_:1R=GN4P:RHJI0'<E2 S(>BN%5B4]
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M(ZG++QXHQV6WF^1RWI17J6"YGEI5<5L37"><N607UXUQB_=V%7#USD[G,K=
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MV)R$3Z =P:98BJ N5^J/7^DT[3JGZ7=*3'!:X0X'I\05#?FJGH+4=:<B.YU
M=*:$;I)&87J-9A+9-37-%X NTX 3V#U9'%RL+?$TIQ:HF,NG!*1:PB9:3EZY
M9CT<#PTN+LJ(;I^JFR>ZNTWW;0X-'(>@)WKB)!3$JK[0A4T\L8O",!D65_"&
M<<+;9(Q<"^Z>0>G,N:2[J 0%6>F+6KU%=994;WE$4QNXJ=FLR']T'-1??CHJ
MU\JDW"9^(/ ,D^KA1JF;\TF;6;=M<<Z9 R9)<5=*)@#-KW0L$N4TAK!VA,Z
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M-U1\8YAV:8YUHB_Q%(: 2!O[!OA#O4H,8Y73//30\H>E8K57!J%*>#/H^>U
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MJ_FQ)V@2[+\:_(J+_%O2?P=02P,$%     @ VS!+5X'#=D@L!   <!$  !
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M#%;"2<P".&,F\Z!.XM(SZ"$>,K;TPL1< TB3*64-$X)C$L#7RN4GB9.XARR
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MU9M=<^(V%(;O=V;_@^K>M#,UQA#2#1.RPY)DAVF^)K#=3F\RPCZ )K+$2"+
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MCY@W\^<Y7?(/4$L! A0#%     @ VS!+5^?3UI_9%@  :I,   X
M     ( !     &0U-3DS-C!D.&LN:'1M4$L! A0#%     @ VS!+5R>-V<$]
M1@  #CT! !$              ( !!1<  &0U-3DS-C!D97@Q,#$N:'1M4$L!
M A0#%     @ VS!+5RQ[^K2:#P  +"T  !$              ( !<5T  &0U
M-3DS-C!D97@Y.3$N:'1M4$L! A0#%     @ VS!+5X'#=D@L!   <!$  !
M             ( !.FT  '=B82TR,#(S,3 Q,"YX<V102P$"% ,4    " #;
M,$M726DB1_ %  #M-0  %               @ &4<0  =V)A+3(P,C,Q,#$P
M7V1E9BYX;6Q02P$"% ,4    " #;,$M7@FS&- L(  !06@  %
M    @ &V=P  =V)A+3(P,C,Q,#$P7VQA8BYX;6Q02P$"% ,4    " #;,$M7
M[.F0,JD%  "V.0  %               @ 'S?P  =V)A+3(P,C,Q,#$P7W!R
;92YX;6Q02P4&      < !P"^ 0  SH4

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
